ES8607319A1 - "un procedimiento para la preparacion de un derivado de ce- falosporina" - Google Patents
"un procedimiento para la preparacion de un derivado de ce- falosporina"Info
- Publication number
- ES8607319A1 ES8607319A1 ES542366A ES542366A ES8607319A1 ES 8607319 A1 ES8607319 A1 ES 8607319A1 ES 542366 A ES542366 A ES 542366A ES 542366 A ES542366 A ES 542366A ES 8607319 A1 ES8607319 A1 ES 8607319A1
- Authority
- ES
- Spain
- Prior art keywords
- cephalosporin derivatives
- preparing
- pharmaceutical compositions
- compositions containing
- gram
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 229930186147 Cephalosporin Natural products 0.000 title abstract 2
- 229940124587 cephalosporin Drugs 0.000 title abstract 2
- 150000001780 cephalosporins Chemical class 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 241000192125 Firmicutes Species 0.000 abstract 1
- 230000000845 anti-microbial effect Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000007927 intramuscular injection Substances 0.000 abstract 1
- 238000010255 intramuscular injection Methods 0.000 abstract 1
- 238000010253 intravenous injection Methods 0.000 abstract 1
- 231100000053 low toxicity Toxicity 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 238000010254 subcutaneous injection Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
- C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
- C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
- C07D213/53—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Cephalosporin Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP59077182A JPS60222490A (ja) | 1984-04-17 | 1984-04-17 | セフアロスポリン誘導体およびその塩 |
| JP59126773A JPS617280A (ja) | 1984-06-20 | 1984-06-20 | セフアロスポリン誘導体 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES542366A0 ES542366A0 (es) | 1986-05-16 |
| ES8607319A1 true ES8607319A1 (es) | 1986-05-16 |
Family
ID=26418289
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES542366A Expired ES8607319A1 (es) | 1984-04-17 | 1985-04-17 | "un procedimiento para la preparacion de un derivado de ce- falosporina" |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US4833242A (en, 2012) |
| EP (1) | EP0159011B1 (en, 2012) |
| KR (1) | KR920002849B1 (en, 2012) |
| AR (1) | AR240826A1 (en, 2012) |
| AU (1) | AU578677B2 (en, 2012) |
| CA (1) | CA1243298A (en, 2012) |
| DE (1) | DE3571987D1 (en, 2012) |
| DK (1) | DK166385A (en, 2012) |
| ES (1) | ES8607319A1 (en, 2012) |
| FI (1) | FI83084C (en, 2012) |
| GR (1) | GR850928B (en, 2012) |
| IE (1) | IE58319B1 (en, 2012) |
| IL (1) | IL74822A (en, 2012) |
| NO (1) | NO165295C (en, 2012) |
| PT (1) | PT80294B (en, 2012) |
| YU (1) | YU43407B (en, 2012) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3811574A1 (de) * | 1988-03-31 | 1989-10-19 | Schering Ag | N-substituierte imidazole, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln |
| US5635521A (en) * | 1991-09-23 | 1997-06-03 | Sandoz Ltd. | Imidazolylmethyl-pyridines |
| EP0554004A3 (en) * | 1992-01-27 | 1993-11-24 | Katayama Seisakusho | Cephem compounds and antibacterial agents |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL61458A0 (en) * | 1979-12-07 | 1980-12-31 | Erba Farmitalia | N-substituted thiazolyl derivatives of oximino-substituted cephalosporins, their preparation and pharmalceutical compositions containing them |
| DE3118732A1 (de) * | 1981-05-12 | 1982-12-02 | Hoechst Ag, 6000 Frankfurt | Cephalosporinderivate und verfahren zu ihrer herstellung |
| US4521413A (en) * | 1981-09-14 | 1985-06-04 | Fujisawa Pharmaceutical Co., Ltd. | Cephem compounds |
| US4563449A (en) * | 1982-07-19 | 1986-01-07 | Fujisawa Pharmaceutical Co., Ltd. | Cephem compounds |
| DE3316797A1 (de) * | 1983-05-07 | 1984-11-08 | Hoechst Ag, 6230 Frankfurt | Verfahren zur herstellung von cephemverbindungen |
| DE3316798A1 (de) * | 1983-05-07 | 1984-11-08 | Hoechst Ag, 6230 Frankfurt | Verfahren zur herstellung von cephemverbindungen |
-
1985
- 1985-04-04 IL IL74822A patent/IL74822A/xx not_active IP Right Cessation
- 1985-04-10 AR AR300020A patent/AR240826A1/es active
- 1985-04-10 CA CA000478729A patent/CA1243298A/en not_active Expired
- 1985-04-11 FI FI851444A patent/FI83084C/fi not_active IP Right Cessation
- 1985-04-12 DK DK166385A patent/DK166385A/da active Protection Beyond IP Right Term
- 1985-04-15 YU YU636/85A patent/YU43407B/xx unknown
- 1985-04-15 NO NO851488A patent/NO165295C/no unknown
- 1985-04-16 GR GR850928A patent/GR850928B/el unknown
- 1985-04-16 IE IE96185A patent/IE58319B1/en not_active IP Right Cessation
- 1985-04-16 DE DE8585104576T patent/DE3571987D1/de not_active Expired
- 1985-04-16 EP EP85104576A patent/EP0159011B1/en not_active Expired
- 1985-04-16 PT PT80294A patent/PT80294B/pt not_active IP Right Cessation
- 1985-04-16 KR KR1019850002542A patent/KR920002849B1/ko not_active Expired
- 1985-04-17 US US06/724,211 patent/US4833242A/en not_active Expired - Fee Related
- 1985-04-17 ES ES542366A patent/ES8607319A1/es not_active Expired
- 1985-04-17 AU AU41333/85A patent/AU578677B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| FI851444A0 (fi) | 1985-04-11 |
| AU578677B2 (en) | 1988-11-03 |
| IE850961L (en) | 1985-10-17 |
| ES542366A0 (es) | 1986-05-16 |
| KR850007425A (ko) | 1985-12-04 |
| AR240826A1 (es) | 1991-02-28 |
| US4833242A (en) | 1989-05-23 |
| EP0159011A3 (en) | 1986-10-08 |
| AR240826A2 (es) | 1991-02-28 |
| KR920002849B1 (ko) | 1992-04-06 |
| NO165295B (no) | 1990-10-15 |
| PT80294A (en) | 1985-05-01 |
| IL74822A0 (en) | 1985-07-31 |
| FI83084B (fi) | 1991-02-15 |
| IL74822A (en) | 1989-06-30 |
| NO851488L (no) | 1985-10-18 |
| GR850928B (en, 2012) | 1985-11-25 |
| DK166385A (da) | 1985-10-18 |
| PT80294B (pt) | 1987-09-30 |
| NO165295C (no) | 1991-01-30 |
| DE3571987D1 (en) | 1989-09-07 |
| EP0159011B1 (en) | 1989-08-02 |
| IE58319B1 (en) | 1993-09-08 |
| FI83084C (fi) | 1991-05-27 |
| YU43407B (en) | 1989-06-30 |
| EP0159011A2 (en) | 1985-10-23 |
| DK166385D0 (da) | 1985-04-12 |
| YU63685A (en) | 1987-10-31 |
| CA1243298A (en) | 1988-10-18 |
| FI851444L (fi) | 1985-10-18 |
| AU4133385A (en) | 1985-10-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GR861625B (en) | Optically active pyridobenzoxazines derivatives and intermediate compounds thereof | |
| GEP20002210B (en) | Acridine Derivatives | |
| UA41865C2 (uk) | Сполуки цефему, що мають антимікробну активність, та фармацевтична композиція, що їх містить | |
| ES2072223A1 (es) | Liposomas encapsulando doxorubicina. | |
| EP0612751A3 (en) | Compounds for the preparation of cephem derivatives. | |
| ES8607319A1 (es) | "un procedimiento para la preparacion de un derivado de ce- falosporina" | |
| JO1629B1 (en) | Andadnodol compounds i | |
| GB1476905A (en) | Cephalosporins processes for their preparation and their use as medicaments | |
| PT78315A (en) | Process for preparing penems and pharmaceutical preparations containing them | |
| HU913520D0 (en) | Process for the production of 7-acyl-3(substituted carbamoiloxy)-cefem-derivatives and of the medical preparations containing them | |
| GB1400287A (en) | Thiadiazole derivatives | |
| GB1235599A (en) | Lincomycin phosphate derivatives and pharmaceutical compositions containing them | |
| ES8607973A1 (es) | Procedimiento para la obtencion de compuestos de amino-alquilo inferior-penem | |
| ES8600758A1 (es) | Procedimiento para preparar derivados de1,3-dioxolanilo | |
| GB1310642A (en) | Alpha-sulfo-and alpha-sulfoalkylacylcephalosporins | |
| EP0487996B1 (de) | 3-substituierte Cephalosporine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel | |
| ES8305378A1 (es) | "procedimiento de obtencion de derivados tiolicos de la eritromicina y del ester propionico de la eritromicina". | |
| MY101079A (en) | Pharmaceutical formulation for the treatment of bacterial infections. | |
| AP9901567A0 (en) | Steroids substituted in composition 11, their preparation process, their use as medicaments and the pharmaceutical compounds containing them. | |
| ES8202332A1 (es) | Un metodo para la preparacion de sales de 4'-(9-acridinila- mino)-metanosulfon-m-anisidida | |
| US3705243A (en) | Antibacterial composition | |
| EP0268267A3 (en) | Guanidinomethylbenzoic acid derivatives, compositions containing the same, processes for preparing the same, and the use of the same in the manufacture of medicaments of therapeutic value | |
| US3729555A (en) | Antibiotic composition | |
| ES8308303A1 (es) | Procedimiento para obtencion de derivados antibioticos de la cepa streptomyces spec. ws 116 | |
| BG103985A (en) | Multicyclic derivatives of erythromycin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD1A | Patent lapsed |
Effective date: 20010201 |